UPDATE 1-US FDA approves Mirum's drug for rare bone disorder

3

(Adds details thoroughout) Sept 25 (Reuters) – The US Food and Drug Administration has approved Mirum Pharmaceuticals' drug to treat a rare bone disorder, the regulator said on Friday. The drug,

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)